Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

US STOCKS-Rotation out of megacaps set to weigh on Nasdaq at open

Published 05/04/2021, 08:59 PM
Updated 05/04/2021, 09:00 PM
© Reuters.

* Pfizer up on lifting annual sales forecast for COVID-19
vaccine
* CVS Health higher on raising 2021 profit outlook
* Futures fall: Nasdaq 0.82%, Dow 0.40%, S&P 0.53%

(Adds details; Updates prices throughout)
By Shreyashi Sanyal
May 4 (Reuters) - The Nasdaq index was set to open lower on
Tuesday as investors continued to move out of megacap growth
stocks and into companies that are expected to benefit from the
reopening of economies.
Highly valued technology companies including Microsoft Corp
MSFT.O , Alphabet Inc GOOGL.O , Apple Inc AAPL.O , Amazon.com
Inc AMZN.O and Facebook Inc FB.O fell between 0.6% and 1.7%
in premarket trading.
U.S. and European stock markets also saw a sudden 0.5% drop
in hefty volumes around 7:30 a.m. ET on Tuesday, leaving traders
scratching their heads and one calling it a "micro flash crash".
Copious stimulus measures, speedy vaccination drives and the
Federal Reserve's accommodative policy stance have spurred a
strong rebound in the U.S. economy and pushed Wall Street to
record highs this year. The so-called "pandemic winners",
however, have recently started to fall out of favor.
"While megacap tech companies have been a core part of the
solid performance of portfolios throughout the pandemic, we
think investors should be careful to avoid overallocation to
this part of the market," Mark Haefele, chief investment officer
at UBS Global Wealth Management, wrote in a client note.
"In an environment of accelerating growth, we continue to
prefer cyclical and value sectors such as financials and
energy."
Planemaker Boeing Co BA.N rose 0.2%, while oil major
Chevron Corp CVX.N gained 0.7%.
At 8:38 a.m. ET, Dow e-minis 1YMcv1 were down 136 points,
or 0.4%, S&P 500 e-minis EScv1 were down 22.25 points, or
0.53%, and Nasdaq 100 e-minis NQcv1 were down 113 points, or
0.82%.
Among other stocks, Pfizer Inc PFE.N rose 1% as it raised
its annual sales forecast for the COVID-19 vaccine it
co-developed with Germany's BioNTech SE BNTX.O . CVS Health Corp CVS.N gained 1.7% on reporting
first-quarter profit above analysts' estimates and raising its
2021 profit forecast. Dupont DD.N edged 0.5% higher after the industrial
materials maker raised its full-year profit and revenue
forecasts and beat first-quarter expectations. First-quarter earnings have been largely upbeat. Average
profits at S&P 500 companies are expected to have risen 46% in
the quarter, compared with forecasts of a 24% growth at the
start of April, according to IBES data from Refinitiv.
Investors also awaited data through the week, including the
Labor Department's non-farm payrolls data, slated to be released
on Friday. The report is expected to show a rise in job
additions in April.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.